Has Henry Kaminski, MD received payments from drug or device companies?

Yes. Drug and device makers reported $83,645 in general payments to Henry Kaminski, MD across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Kaminski, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Kaminski, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Kaminski, MD

Neurology · Washington Dc, DCNPI 1104844695

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $60,773 of the $83,645 with a category attached, or 72.7%. UCB SA accounts for 72.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $29,659, 3.2 times the $9,345 reported in 2019.

$83,645in general payments, 2019–2025

Across 39 payments — averaging $2144.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB SA$61K
Merck Healthcare Kgaa$7K
F. Hoffmann-la Roche AG$5K
Novartis$4K
Merck Kgaa$4K
AstraZeneca$1K
plus $2K from 7 others

$552,856in research payments, 2019–2025

Across 95 payments — averaging $5819.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

UCB SA$383K
Genentech, Inc.$75K
Ares Trading SA$29K
UCB Biosciences Inc.$22K
Takeda Pharmaceuticals U.S.A., Inc.$21K
UCB, Inc.$21K
plus $2K from 2 others

What the payments were for

Consulting fees$60,77373%
Speaking & faculty fees$1,4752%
Travel & lodging$20,60325%
Food & beverage$7941%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB SA	22	$60,686
Merck Healthcare Kgaa	2	$6,900
F. Hoffmann-la Roche AG	2	$4,500
Novartis	1	$4,125
Merck Kgaa	1	$3,600
AstraZeneca	1	$1,475
Samsung Bioepis Co., Ltd.	1	$1,100
Sanofi US Services Inc.	1	$470
UCB, Inc.	4	$430
Penumbra, Inc.	1	$146
Johnson & Johnson	1	$121
Sarepta Therapeutics, Inc.	1	$75
AbbVie	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,645 in reported general payments places this provider in the 85th percentile of 113 neurology providers in District of Columbia.

See all neurology providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$36,431

Medicare patients

Services billed

736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50	33	$466,543
Gamunex-CImmune Globul G/Gly/Iga Avg 46	42	$345,450
PrivigenImmun Glob G(Igg)/Pro/Iga 0-50	21	$327,401
Mycophenolate Mofetil	89	$20,596
Pyridostigmine Bromide	63	$5,688
Tacrolimus	20	$5,168
Prednisone	128	$1,884
Azathioprine	12	$763
Sodium Chloride0.9 % Sodium Chloride	14	$200

Paid to pharmacies, not to this prescriber.

Other neurology in Washington Dc

Laxman BahrooWashington$3.1M
Fahd AmjadWashington$2M
Jessica AilaniWashington$1.2M
Yasar Torres-YaghiWashington$969K
Benjamin OsborneWashington$747K
Fernando PaganWashington$690K
Faria AmjadWashington$557K
Brian BarryWashington$359K
Carrie DoughertyWashington$327K
Carlo TornatoreWashington$318K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →